» Articles » PMID: 28928862

Discovering the MiR-26a-5p Targetome in Prostate Cancer Cells

Overview
Journal J Cancer
Specialty Oncology
Date 2017 Sep 21
PMID 28928862
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

miR-26a-5p is a tumor suppressor (TS) miRNA often downregulated in several tumor tissues and tumor cell lines. In this work, we performed the re-expression of the miR-26a-5p in DU-145 prostate cancer cells to collect genes interacting with miR-26a-5p and analyzed their integration in the tumorigenesis related pathways. The transfection of DU-145 prostate cancer cells with miR-26a-5p was done using nucleofection. The biological effects induced by miR-26a-5p re-expression were detected with routine assays for cell proliferation, cell cycle, survival, apoptosis and cell migration. The miRNA pull out technique was used to collect and next generation sequencing to identify the complete repertoire of the miR-26a-5p targets (miR-26a-5p/targetome). TargetScan 7, PITA and RNA22 were used to find the predicted miR-26a-5p targets in the miR-26a-5p/targetome. Gene set enrichment analysis were used to integrate target genes in KEGG pathways and Protein-Protein Interaction networks (PPINs) and modules were built. miR-26a-5p exerted an anti-proliferative effect acting at several levels, by decreasing survival and migration and inducing both cell cycle block and apoptosis The analysis of the miR-26a-5p/targetome showed that 1423 (1352 coding and 71 non-coding) transcripts interacted with miR-26a-5p. Filtering the miR-26a-5p/targetome with prediction algorithms, 628 out of 1353 transcripts were miR-26a-5p predicted targets and 73 of them were already validated miR-26a-5p targets. Finally, miR-26a-5p targets were involved in 22 KEGG pathways and 20 significant protein-protein interaction modules The TS-miR-26a-5p/targetome is a platform that shows both unknown and known miRNA/target interactions thus offering the possibility to validate genes and discover pathways in which these genes could be involved.

Citing Articles

IsomiR-eQTL: A Cancer-Specific Expression Quantitative Trait Loci Database of miRNAs and Their Isoforms.

Moradi A, Whatmore P, Farashi S, Barrero R, Batra J Int J Mol Sci. 2022; 23(20).

PMID: 36293349 PMC: 9604134. DOI: 10.3390/ijms232012493.


The Role of Non-Coding RNAs in Chromosomal Instability in Cancer.

Mohapatra S, Winkle M, Ton A, Nguyen D, Calin G J Pharmacol Exp Ther. 2022; 384(1):10-19.

PMID: 36167417 PMC: 9827503. DOI: 10.1124/jpet.122.001357.


MiR-26a-5p as a useful therapeutic target for upper tract urothelial carcinoma by regulating WNT5A/β-catenin signaling.

Chung Y, Cheng Y, Kao Y, Tsai W, Huang G, Chen Y Sci Rep. 2022; 12(1):6955.

PMID: 35484165 PMC: 9050734. DOI: 10.1038/s41598-022-08091-6.


Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool.

Herrero-Aguayo V, Saez-Martinez P, Jimenez-Vacas J, Moreno-Montilla M, Montero-Hidalgo A, Perez-Gomez J Mol Ther Nucleic Acids. 2022; 27:1164-1178.

PMID: 35282415 PMC: 8889365. DOI: 10.1016/j.omtn.2022.02.010.


Contribution of miRNAs, tRNAs and tRFs to Aberrant Signaling and Translation Deregulation in Lung Cancer.

Skeparnias I, Anastasakis D, Grafanaki K, Kyriakopoulos G, Alexopoulos P, Dougenis D Cancers (Basel). 2020; 12(10).

PMID: 33092114 PMC: 7593945. DOI: 10.3390/cancers12103056.


References
1.
Helwak A, Kudla G, Dudnakova T, Tollervey D . Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013; 153(3):654-65. PMC: 3650559. DOI: 10.1016/j.cell.2013.03.043. View

2.
Chen J, Zhang K, Xu Y, Gao Y, Li C, Wang R . The role of microRNA-26a in human cancer progression and clinical application. Tumour Biol. 2016; 37(6):7095-108. DOI: 10.1007/s13277-016-5017-y. View

3.
Zhu Y, Yu M, Li Z, Kong C, Bi J, Li J . ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival. Urology. 2010; 77(2):510.e1-5. DOI: 10.1016/j.urology.2010.09.022. View

4.
Patella F, Leucci E, Evangelista M, Parker B, Wen J, Mercatanti A . MiR-492 impairs the angiogenic potential of endothelial cells. J Cell Mol Med. 2013; 17(8):1006-15. PMC: 3780533. DOI: 10.1111/jcmm.12085. View

5.
Cai Y, Ma W, Huang X, Cao L, Li H, Jiang Y . Effect of survivin on tumor growth of colorectal cancer in vivo. Int J Clin Exp Pathol. 2016; 8(10):13267-72. PMC: 4680473. View